Article info

Download PDFPDF

Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials

Authors

  • Jia-Wei Lv Department of Radiation OncologySun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy 651 Dongfeng Road East 510060 Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Jun-Yan Li Department of Radiation OncologySun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy 651 Dongfeng Road East 510060 Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Lin-Na Luo Department of Medical OncologySun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Zi-Xian Wang Department of Medical OncologySun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  • Yu-Pei Chen Department of Radiation OncologySun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy 651 Dongfeng Road East 510060 Guangzhou People’s Republic of China PubMed articlesGoogle scholar articles
  1. d +86-20-87343795 wangzx{at}sysucc.org.cn
  2. e +86-20-87343469 chenyup1{at}sysucc.org.cn
View Full Text

Citation

Lv J, Li J, Luo L, et al
Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials

Publication history

  • Received January 2, 2019
  • Accepted June 12, 2019
  • First published June 25, 2019.
Online issue publication 
June 25, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.